image
Altamira Therapeutics Ltd. CYTO
Healthcare - Biotechnology - NASDAQ - BM
Watchlist
$ 0.4554
5.91 %
$ 1.72 M
Market Cap
0.25
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% 72.60% 77.36%
Annual Report FY 10-K 2022-12-31 378.41% -52.55% -52.82%
Annual Report FY 10-K 2021-12-31 -63.39% -112.07% -223.67%
Annual Report FY 10-K 2020-12-31 411.56% -23.65% 27.22%
Annual Report FY 10-K 2019-12-31 -4.42% 42.31% 33.73%
Annual Report FY 10-K 2018-12-31 293.17% 52.90% 55.03%
Annual Report FY 10-K 2017-12-31 177.78% 20.39% 19.40%
Annual Report FY 10-K 2016-12-31 -517.91% -3.22% 2.12%
Annual Report FY 10-K 2015-12-31 -2.23% -63.35% -39.13%
Annual Report FY 10-K 2014-12-31 0.00% -21.20% -51.85%
Annual Report FY 10-K 2013-12-31 0.00% -226.01% -217.01%
Annual Report FY 10-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2023-06-30 -63.73% 34.20% 45.50%
Quarterly Report Q1 8-K 2023-03-31 -63.73% 34.20% 45.50%
Quarterly Report Q4 8-K 2022-12-31 0.00% -15.37% 7.62%
Quarterly Report Q3 8-K 2022-09-30 0.00% -86.55% 28.81%
Quarterly Report Q2 8-K 2022-06-30 0.00% -21.97% -30.36%
Quarterly Report Q1 8-K 2022-03-31 0.00% -21.97% -30.36%
Quarterly Report Q4 8-K 2021-12-31 0.00% 288.33% 484.68%
Quarterly Report Q3 8-K 2021-09-30 0.00% -85.93% -206.81%
Quarterly Report Q2 8-K 2021-06-30 0.00% -154.07% -166.70%
Quarterly Report Q1 8-K 2021-03-31 0.00% -154.07% -166.70%
Quarterly Report Q4 8-K 2020-12-31 523.21% -83.04% 9.17%
Quarterly Report Q3 8-K 2020-09-30 0.00% -83.04% 9.17%
Quarterly Report Q2 8-K 2020-06-30 0.00% 26.24% 41.07%
Quarterly Report Q1 8-K 2020-03-31 0.00% 26.24% 41.07%
Quarterly Report Q4 8-K 2019-12-31 -4.42% 58.99% -135.27%
Quarterly Report Q3 8-K 2019-09-30 0.00% 49.21% 45.04%
Quarterly Report Q2 8-K 2019-06-30 0.00% 41.48% 34.03%
Quarterly Report Q1 8-K 2019-03-31 0.00% -3.25% 52.28%
Quarterly Report Q4 8-K 2018-12-31 293.17% 19.51% 87.68%
Quarterly Report Q3 8-K 2018-09-30 0.00% 50.43% 48.41%
Quarterly Report Q2 8-K 2018-06-30 0.00% 43.09% 47.75%
Quarterly Report Q1 8-K 2018-03-31 0.00% 79.22% 41.89%
Quarterly Report Q4 8-K 2017-12-31 177.78% 15.70% 13.89%
Quarterly Report Q3 8-K 2017-09-30 0.00% 23.82% 26.31%
Quarterly Report Q2 8-K 2017-06-30 0.00% 35.82% 33.82%
Quarterly Report Q1 8-K 2017-03-31 0.00% 5.60% -0.61%
Quarterly Report Q4 8-K 2016-12-31 -517.91% 0.81% 6.80%
Quarterly Report Q3 8-K 2016-09-30 0.00% -51.45% -4.59%
Quarterly Report Q2 8-K 2016-06-30 0.00% 23.05% 7.48%
Quarterly Report Q1 8-K 2016-03-31 0.00% -10.52% -2.83%
Quarterly Report Q4 8-K 2015-12-31 -2.23% -38.03% -20.89%
Quarterly Report Q3 8-K 2015-09-30 0.00% -55.05% -26.86%
Quarterly Report Q2 8-K 2015-06-30 0.00% -119.55% -92.85%
Quarterly Report Q1 8-K 2015-03-31 0.00% -37.41% -22.22%
Quarterly Report Q4 8-K 2014-12-31 0.00% -13.55% -70.97%
Quarterly Report Q3 8-K 2014-09-30 0.00% 24.12% -34.67%
Quarterly Report Q2 8-K 2014-06-30 0.00% -2.98% -3.55%
Quarterly Report Q1 8-K 2014-03-31 0.00% -162.79% -161.13%
Quarterly Report Q4 8-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2013-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%